Tudor Investment Corp
DCPH

Tudor Investment Corp’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Tudor Investment Corp’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-39,525
Closed -$622K – 2913
2024
Q1 		$622K Buy
+39,525
New +$608K ﹤0.01% 1548
2023
Q4 		– Sell
-42,238
Closed -$537K – 3008
2023
Q3 		$537K Buy
+42,238
New +$583K 0.01% 1638
2022
Q4 		– Sell
-33,187
Closed -$614K – 2950
2022
Q3 		$614K Buy
+33,187
New +$521K 0.01% 1251
2022
Q2 		– Sell
-49,084
Closed -$455K – 2606
2022
Q1 		$455K Buy
+49,084
New +$417K 0.01% 1320
2021
Q2 		– Sell
-15,890
Closed -$713K – 2029
2021
Q1 		$713K Sell
15,890
-15,941
-50% -$742K 0.01% 995
2020
Q4 		$1.82M Buy
+31,831
New +$1.89M 0.05% 452
2017
Q4 		– Sell
-52,630
Closed -$999K – 1322
2017
Q3 		$999K Buy
+52,630
New +$964K 0.03% 394

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Tudor Investment Corp's DCPH Position: Q2 2024 in Review

Tudor Investment Corp sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 39,525 shares — an estimated $622K sold.

Tudor Investment Corp first reported a position in DCPH in Q3 2017 and held it in 7 quarters. The position peaked at $1.82M in Q4 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Tudor Investment Corp reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 39,525 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $622K.
  • Tudor Investment Corp first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 7 quarters.
  • Tudor Investment Corp's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.82M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.